Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2021

May 28, 2021

32566_dirs_2021-05-28_25ac9f79-8029-4326-aeaf-57580976368c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-05-14

Reporting Person: Parkinson Paul (Fmr EVP Strategy & Innovation)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 87407 Direct